Akouos, Inc. (a wholly owned subsidiary of Eli Lilly and Company), United States
Disclosure information not submitted.
Rationale and Trial Design for an AK-antiVEGF Gene Therapy Trial for Vestibular Schwannoma
Monday, October 13, 2025
9:48 AM - 9:54 AM EDT